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Abstract
MicroRNAs (miRNAs) are short, non-coding RNAs, which post-transcriptionally regulate gene expression and are proposed
to play a key role in the regulation of innate and adaptive immunity. Here, we report a next generation sequencing (NGS)
approach profiling the expression of miRNAs in primary bovine mammary epithelial cells (BMEs) at 1, 2, 4 and 6 hours post-
infection with Streptococcus uberis, a causative agent of bovine mastitis. Analysing over 450 million sequencing reads, we
found that 20% of the approximately 1,300 currently known bovine miRNAs are expressed in unchallenged BMEs. We also
identified the expression of more than 20 potentially novel bovine miRNAs. There is, however, a significant dynamic range in
the expression of known miRNAs. The top 10 highly expressed miRNAs account for .80% of all aligned reads, with the
remaining miRNAs showing much lower expression. Twenty-one miRNAs were identified as significantly differentially
expressed post-infection with S. uberis. Several of these miRNAs have characterised roles in the immune systems of other
species. This miRNA response to the Gram-positive S. uberis is markedly different, however, to lipopolysaccharide (LPS)
induced miRNA expression. Of 145 miRNAs identified in the literature as being LPS responsive, only 9 were also differentially
expressed in response to S. uberis. Computational analysis has also revealed that the predicted target genes of miRNAs,
which are down-regulated in BMEs following S. uberis infection, are statistically enriched for roles in innate immunity. This
suggests that miRNAs, which potentially act as central regulators of gene expression responses to a Gram-positive bacterial
infection, may significantly regulate the sentinel capacity of mammary epithelial cells to mobilise the innate immune
system.
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Introduction
MicroRNAs (miRNAs) are an abundant class of highly
conserved, small (19–24 nt long), non-coding, double-stranded
RNA molecules. They act as post-transcriptional regulators of
gene expression, altering mRNA stability and translation efficiency
by hybridizing to the 39 untranslated regions (UTRs) of certain
subsets of mRNAs (collectively as many as 60% of all mRNA
transcripts) [1]. Since their initial discovery in Caenorhabditis elegans
in 1993 [2], researchers have gained much insight into the
prevalence of miRNAs in other species. The latest miRBase
database (release 19) contains 21,264 precursor miRNAs, expres-
sing 25,141 mature miRNA products, in 193 species [3].
miRNAs have been shown to play key roles in the regulation of
innate and adaptive immunity in humans and mice [4]. miR-146a,
for example, regulates the innate immune response to bacterial
infection, targeting TNF receptor-associated factor 6 (TRAF6) and
Interleukin-1 receptor-associated kinase 1 (IRAK1) [5], while
miR-150 regulates the production of mature B cells [6]. Studies
elucidating the regulatory roles of miRNAs in bovine infection and
immunity, however, are more limited. Bovine miRNAs have been
shown to be expressed in a wide range of tissues, including
immune-related ones [7,8,9], but only a handful of studies have
investigated how the expression of bovine miRNAs are altered in
response to infection. A recent RT-qPCR study, for example,
highlighted the differential expression of five inflammation related
miRNAs (miR-9, miR-125b, miR-155, miR-146a and miR-223) in
response to E. coli lipopolysaccharide (LPS) and S. aureus
enterotoxin B stimulation of bovine monocytes [10]. Two other
recent studies have used a similar approach to identify several
miRNAs that were differentially expressed in the mammary gland
tissue of cattle with mastitis [11,12]. These and other studies
suggest roles for individual miRNAs in regulating bovine
immunity, however, according to Ensembl v66 [13,14] there are
over 1,300 annotated miRNAs in the bovine genome. Therefore,
studies which adopt genome-wide approaches are required to gain
greater insight into the repertoire of bovine miRNAs involved in
immunity and infection.
Although microarray technologies to profile miRNA expression
have been around for some time [15], next generation sequencing
(NGS) based technologies are revolutionising the field and provide
the opportunity to profile the expression of known miRNAs with
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discriminating resolution and accuracy, and also to identify novel
miRNAs [16]. Furthermore, these technologies allow one to
differentiate between the expression of alternative mature
miRNAs from the same precursor and to identify the differential
expression of miRNA isomiRs [17]. To date, a limited number of
studies have applied these approaches to profile miRNAs in
different bovine tissues [18,19,20] and only one study has used an
NGS approach to investigate the expression of bovine miRNAs in
response to infection [21].
In this study, we implemented a NGS approach to profile the
expression of bovine miRNAs at multiple time-points in primary
mammary epithelial cells infected in vitro with Streptococcus uberis,
a causative agent of bovine mastitis. This inflammatory disease of
the mammary gland has significant economic impact on the global
dairy industry [22–23]. To the best of our knowledge, this study
represents the most comprehensive NGS study to date that profiles
the host miRNA response to infection, in any species. In
comparison to previous studies, we have sequenced un-pooled
miRNA libraries to a previously unprecedented sequencing depth
from multiple replicates and controls across multiple time-points,
allowing us to explore the statistically significant temporal changes
in miRNA expression in response to infection.
Materials and Methods
Bovine Mammary Epithelial Cell Culture
Primary bovine mammary epithelial cells, which had been
isolated from mammary parenchyma, were purchased from
AvantiCell (AvantiCell Science Ltd., Ayr, UK) [24,25]. The
source animal was in her third trimester of first pregnancy, was
aged between 26–30 months, and was negative for bovine viral
diarrhoea and Bovine spongiform encephalopathy. Cells were
plated (seed density of 16106) directly onto collagen coated plastic
flasks (Greiner-Bio-One GmbH, Frickenhausen, Germany) and
immersed in AvantiCell medium – (199/Ham’s F12 (50:50)
pH 7.4 containing 5% (v/v) horse serum, 5% (v/v) fetal bovine
serum, 5 mg/ml bovine insulin, 1 mg/ml hydrocortisone, 3 mg/ml
cortisol, 10 ng/ml epidermal growth factor (EGF), 2 mM sodium
acetate, 10 mM Hepes, U/ml penicillin/streptomycin and single
strength FungizoneTM).
Media was initially replaced after 48 h. Cells were split twice
(75 cm2 and 175 cm2) and were then seeded at a concentration of
1.86105 cells/well into collagen coated 6-well plates. Media was
then changed after 24 h, and cells were inspected under
microscopy for confluence. Cells were harvested by washing with
Hanks Balanced Salt Solution (HBSS) pH 7.4 and treated with
4 ml of 0.25% trypsin for approximately 5 min at 37uC. An equal
volume of medium to trypsin (1:1) neutralised trypsin.
Infection of Cells with Streptococcus uberis 0140J
Streptococcus uberis 0140J was purchased from the American Type
Culture Collection (ATCC), Virginia, USA (Cat# BAA-854). S.
uberis 0140J was first isolated in milk obtained from a clinical case
of bovine mastitis in the United Kingdom in 1972. S. uberis was
cultured as per ATCC instructions. BMEs were challenged with S.
uberis 0140J at a multiplicity of infection (MOI) of 50, over a time
course of 1, 2, 4, & 6 h. Three replicates were infected at each
time point and three replicate uninfected controls were also
maintained for each time point.
miRNA Extraction
Total RNA and small RNA was extracted from each of the 24
samples using the mirVanaTM miRNA Isolation Kit (Life
Technologies, Carlsbad, CA, USA). Procedures were performed
according to the manufacturer’s protocol. Briefly, cells were lysed
using 500 ml lysis/binding solution directly on a culture plate.
50 ml of miRNA homogenate was added; solution was mixed by
vortexing and left on ice for 10 min. 500 ml of acid-phenol
chloroform was added and solution was mixed by vortexing for
,60 sec. The solution was then centrifuged for 5 min at 10,0006g
at room temperature to separate phases. Aqueous phase was
removed and transferred to a separate tube. 1/3 volume of 100%
ethanol was added to the aqueous phase and mixed by vortexing.
Samples were passed through a filter cartridge (glass-fiber filter) by
centrifuge for ,30 sec at 10,0006g. The filtrate was collected
(residue on filter contained RNA ,200 nt, was retained for later
use) and 2/3 volume 100% ethanol was added and mixed by
vortexing. Filtrate was passed through a second filter cartridge by
centrifuge for ,30 sec at 10,0006g. The flow through was
discarded, and the filter was washed with 700 ml wash solution 1
and 500 ml wash solution 2 (twice). After discarding all flow
through after each step, the filter was centrifuged for a further
1 min. 50 ml of pre-heated (95uC) nuclease free water was applied
to the filter for 1 min, and the filter was centrifuged for 30 sec.
Eluate was collected and stored at 280uC. Total RNA integrity
was measured by the Agilent RNA 6000 Nano Kit using the 2100
Bioanalyzer (Agilent Technologies, Colorado Springs, CO, USA).
The Agilent Small RNA Kit (Agilent Technologies) was used to
quantify miRNA.
Small RNAseq Library Preparation and Sequencing
Twenty-four indexed miRNA libraries were prepared using the
ScriptMinerTM Small RNAseq Library Preparation Kit (Epicen-
tre, Madison, WI, USA). Procedures were performed according to
the manufacturer’s protocol. Briefly, a 39-tagging sequence was
added to the 39- end of the RNA followed by treatment with
a degradase enzyme to reduce excess 39 adaptor oligo. A tagging
sequence was then added to the 59- end of the RNA. The RNA,
now tagged at both ends (di-tagged), was purified using the
Zymogen RNA Clean and Concentrator (Zymogen, Irvine, CA,
USA). The di-tagged RNA was then reverse transcribed into
cDNA, and the remaining RNA was removed using RNase. The
PCR step used by the ScriptMinerTM kit, is a two stage process,
firstly an analytical PCR step was carried out to optimise the
number of cycles necessary for amplification. Once this was
determined, the libraries were amplified and adaptors were added.
Size fractionation of the miRNA libraries to separate them from
adapter dimers was achieved by electrophoresis on an 8% TBE
polyacrylamide gel (Life Technologies, Carlsbad, CA, USA)
(1.00 mm610 well). The libraries were then purified from the
gel and the Agilent High Sensitivity DNA Kit (Agilent Technol-
ogies, Colorado Springs, CO, USA) was used to quantify the
molarity and size of finished miRNA-seq libraries. miRNA
libraries were randomised across three lanes of a flowcell, with
eight indexed samples on each lane. Libraries were sequenced on
an Illumina HiSeq 2000 by the Norwegian Sequencing Centre
with TruSeq v3 reagents. Fastq files were produced using the
CASAVA pipeline v1.8.2. Barcodes (indexes) and adaptor
sequences for multiplexed samples are provided (Table S1).
Small RNAseq Analysis
Preliminary quality control analysis of the 24 fastq files was
carried out with FASTQC software v0.10.0 (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc/). Cutadapt v1.1
(http://www.cutadapt/) was then used to trim 39 adaptor
sequences. Reads which were shorter than 18 nucleotides after
trimming were discarded. Trimmed reads were then further
filtered using the fastq quality filter (http://hannonlab.cshl.edu/
Bovine miRNA Response to S. uberis
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e57543
fastx_toolkit/) v0.0.13. Reads where at least 50% of the bases had
a Phred score ,20 were removed [26]. Finally, reads passing all
the above filters were also trimmed at their ends to remove low
quality bases (Phred score ,20). Reads which successfully passed
filtering were aligned to the bovine genome (UMD3.1) using
novoalign version 2.07.11 (http://www.novocraft.com) using the
‘‘-m’’ miRNA mode. Reads that did not uniquely align to the
genome were discarded. HTSeq version 0.5.3p3 (http://www-
huber.embl.de/users/anders/HTSeq/doc/overview.html) using
the union model was used to assign uniquely aligned reads to
Ensembl (v66) bovine gene and miRNA annotation (separately).
miRNAseq fastq files have been submitted to the NCBI Gene
Expression Omnibus (GEO) database [27] with experiment series
accession number GSE41278.
Differential Expression Analysis
Prior to assessing differential expression, count data were first
normalised across libraries using either the trimmed mean of M-
values (TMM) normalisation method [28] or upper-quantile
normalisation [29]. Differential expression analysis of miRNAseq
data has been shown to be sensitive to the normalisation approach
implemented [30]. To address this issue, we identified differen-
tially expressed miRNAs in three alternatively normalised datasets;
TMM-normalised, upper-quantile normalised and no normal-
isation. Only miRNAs which were identified as differentially
expressed across all three datasets were considered further i.e. the
differential expression of these miRNAs was robust to the
normalisation procedure. As an aside, we found that the two
different normalisation approaches resulted in very similar
miRNAs being detected as differentially expressed.
The R (version 2.14.1) Bioconductor package EdgeR (v2.4.6)
[28], which uses a negative binomial distribution model to account
for both biological and technical variability was applied to identify
statistically significant differentially expressed miRNAs. Only
miRNAs that had at least 1 count per million in at least 3 samples
were analysed for evidence of differential gene expression. The
analysis was undertaken using moderated tagwise dispersions.
Differentially expressed miRNAs were defined as having a Benja-
mini and Hochberg [31] corrected P value of ,0.05.
Novel miRNA Discovery
In addition to profiling the expression of known miRNAs,
miRNAseq data can also be used to identify the expression of
potentially novel miRNAs. To do this, miRNAseq data from this
study was analysed using the software package miRDeep2 v0.0.5
[32]. The miRDeep2 algorithm mines high-throughput sequenc-
ing data for the presence of multiple sequenced RNAs correspond-
ing to predicted miRNA hairpin structures in the genome. It then
uses Bayesian statistics to score the fit of sequenced RNAs to the
biological model of miRNA biogenesis. MiRDeep2 predicted
a large number of potentially novel miRNAs from our miRNAseq
data. We further parsed this data using a number of different
parameters to identify those novel miRNAs that have the highest
likelihood of being true positives. Specifically, we identified those
predictions where both the mature and star stands were expressed
with a minimum of 5 reads each; where miRDeep2 predicted that
the miRNA had .90% probability of being a true positive; where
the hairpin structure had a significant Randfold p-value and where
the novel miRNA was independently predicted in two or more
different miRNAseq samples.
Customised Perl scripts were also written in house to examine
the miRDeep2 output for the presence of miRNA isomiRs. These
scripts were used to identify isomiRs that were expressed at a level
of at least 100 reads and to identify cases where the expression of
the isomiR was higher than the expression of the miRBase
consensus mature sequence. Furthermore, we identified whether
isomiRs were modified at the 59 or 39 ends (first and last 5
nucleotides). IsomiRs with.1 mismatch to the reference sequence
were excluded from the analysis.
miRNA Target Predictions
Target genes that are potentially regulated by differentially
expressed miRNAs were predicted using the consensus of two
computational approaches, miRanda v3.3a [33] and TargetScan
v6.2 [34,35,36]. Given the high false positive rates for miRNA
target prediction, we identified only those potential target genes
that were predicted by both methods. More specifically, we first
established a broad pool of potential targets by applying miRanda
to bovine mature miRNA (miRBase v18) and cDNA sequences
(UMD3.1, Ensembl v66) under default threshold settings. This
resulted in the prediction of thousands of possible target genes per
differentially expressed miRNA. To narrow down this pool of
potential targets, we used TargetScan to independently identify
conserved targets with a PCT-score above 0.9 and/or non-
conserved targets with a context+ score above 90%. Target genes
that were not corroborated by one of the two methods were
discarded. Pathway analysis of predicted gene targets was un-
dertaken using the SIGORA R package (http://cran.r-project.
org/web/packages/sigora/index.html) with KEGG pathway an-
notations [37]. Genes that have an annotated role in innate
immunity were identified using www.innatedb.com [38], a curated
database of innate immunity genes, pathways and molecular
interactions.
Results
Isolation of Small RNA from Bovine Mammary Epithelial
Cells
Small RNA was isolated for NGS sequencing from S. uberis
infected primary bovine mammary epithelial cells at 1, 2, 4 and 6
hours post-infection (hpi) (n = 3 infected and n= 3 controls at each
time-point). Total RNA and small RNA were examined for
quantity and integrity in each of the 24 samples (Table S2). Total
RNA was assessed to be of high quality based on both Bioanalyzer
and 28S/18S analysis. RNA integrity numbers (RIN) for total
RNA were .8 for each sample. The concentration of miRNA in
Figure 1. The proportion of reads aligning uniquely to bovine
ncRNAs (averaged across 24 samples). The vast majority of reads
aligned to known miRNAs.
doi:10.1371/journal.pone.0057543.g001
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each sample was also assessed (Table S2). Sufficient quantities
were present to proceed with RNAseq library preparation.
High-throughput Sequencing of Small RNA Libraries
Prepared from Bovine Mammary Epithelial Cells
Small RNA libraries were prepared from size selected RNA
(,200 nucleotides). Libraries were prepared using the ScriptMi-
nerTM protocol with indexing before cluster generation, sequenc-
ing and imaging on an Illumina Hiseq 2000. Samples were
randomly multiplexed over 3 flowcell lanes for sequencing.
Sequencing of small RNA libraries yielded more than 450 million
raw sequence reads from mammary epithelial cells. Following
a pipeline of adaptor removal, quality filtering and the removal of
sequences that were too short, more than 213 million reads were
retained for further analysis (78,604,161 and 134,850,887 for
control and infected replicates, respectively). These filtered reads
were then aligned to the reference Bos taurus UMD 3.1 genome.
Over 116 million reads aligned uniquely to the genome (Table S1).
Reads that aligned to more than one position in the genome were
discarded. Uniquely aligning reads were then assigned to known
miRNAs using HTseq (http://www-huber.embl.de/users/
anders/HTSeq/doc/overview.html) based on Ensembl v66
[13,14] annotation of the bovine genome.
Repertoire of RNA Species in Small RNA Libraries
The proportion of reads (averaged across 24 samples) uniquely
aligning to different RNA biotypes demonstrates that miRNAs are
the dominant ncRNA species sequenced in our small RNA
libraries (Figure 1). The vast majority (.90%) of reads that align
uniquely to known ncRNAs align to known miRNAs. There was
no significant difference in the proportion of reads aligning to
different RNA biotypes in the infected and control samples. The
majority of the remaining reads primarily mapped to snoRNAs
(Figure 1) [20]. Although the vast majority of reads align to known
bovine ncRNAs, a low density of reads can be observed along each
Figure 2. The genomic position of bovine mammary epithelial cell expressed miRNAs with .100 tpm (red). The position of other
annotated bovine miRNAs is shown (blue).
doi:10.1371/journal.pone.0057543.g002
Figure 3. The top 10 most highly expressed miRNAs is bovine mammary epithelial cells.
doi:10.1371/journal.pone.0057543.g003
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chromosome (Figure S1). These possibly represent mRNA
degradation products.
The Expression of miRNAs in Primary Bovine Mammary
Epithelial Cells
To characterise the bovine mammary epithelial cell micro-
RNome, miRNAs that were expressed at an appreciable level
(based on mapped read counts in tags per million sequenced (tpm))
were identified. 276 miRNAs had a count of greater than 1 tpm
(Table S3). Of these, 114 miRNAs were expressed at a level
.100 tpm. To determine whether these miRNAs were expressed
from related genomic regions, we examined all miRNAs with
.100 tpm for genomic clustering (Figure 2). There was no
evidence of a substantial genomic bias from which these miRNAs
were encoded.
The top 10 highly expressed miRNAs, which accounted for
.80% of all aligned reads (Figure 3), were evolutionarily
conserved across multiple species. These miRNAs represent seven
different miRNA families; miR-let-7 (bta-let-7i & bta-miR-3596),
miR-21 (bta-miR-21), miR-27 (bta-miR-27a & bta-miR-27b),
miR-28 (bta-miR-151), miR-184 (bta-miR-184), miR-200 (bta-
miR-200a & bta-miR-200b), and miR-205 (bta-miR-205). Many
of these miRNAs have been shown to have pleiotropic roles in
other species (Table 1). miR-21 and miR-205, have been shown to
have role in cancer, regulating tumour suppressor genes such as
VEGF-A and TGFI-R2 [39,40,41,42].
Of particular interest to our study is the fact that several of the
most highly expressed miRNAs in BMEs have been shown to have
a role in immunity. miR-27b, for example, has been shown to
negatively regulate the mRNA stability of peroxisome proliferator-
activated receptor gamma (PPARgamma), a transcriptional reg-
ulator of the inflammatory response [43]. Interestingly, miR-27b
has also been found to be degraded by a viral transcript in lytic
murine cytomegalovirus (MCMV) infection, further highlighting
its role in immunity [44]. miR-21 has also recently been shown to
be the most highly expressed miRNA in Mycobacterium leprae
infected monocytes and to negatively regulate the Vitamin D-
dependent antimicrobial pathway [45]. Evidence from previous
Table 1. Highly expressed miRNAs in bovine mammary epithelial cells have been shown to have pleiotropic functions in other
species.
miRNA Species Tissue Target Function Reference
miR-21 Human Monocytes CAMP/DEFB4A Immune [45]
miR-21 Human Colon Cancer Cell TGFI-R2 Cancer [42]
miR-184 Human HeLa/HEK SHIP2 Immune [46]
miR-205 Human MCF-7, MDA-MB-231, MDA-MB-453 and MDA-MB-468 cells VEGF-A Cancer [39–40]
miR-27b Human Monocytes PPARgamma Immune [43]
doi:10.1371/journal.pone.0057543.t001
Figure 4. Differentially expressed miRNAs at 2 hours post-infection (hpi).
doi:10.1371/journal.pone.0057543.g004
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studies also suggests that highly expressed miRNAs in BMEs may
also regulate each other. miR-184, for example, has been
demonstrated to antagonise miR-205 to maintain SHIP2 levels
in epithelia [46].
Multiple miRNAs are Differentially Expressed in Response
to S. uberis Infection
Once we had characterised which miRNAs were expressed in
unchallenged bovine mammary epithelial cells, we then utilised
the EdgeR statistical package [28] to determine which miRNAs
were significantly differentially expressed in response to S. uberis
infection at 1, 2, 4 and 6 hpi. It has been suggested that differential
expression analysis of miRNAseq is sensitive to the normalisation
approach implemented [30]. To address this issue, we identified
differentially expressed miRNAs in three alternatively normalised
datasets; TMM-normalised [29], upper-quantile normalised and
no normalisation. Only miRNAs which were identified as
differentially expressed across all three datasets were considered
as significantly differentially expressed i.e. the differential expres-
sion of these miRNAs was robust to the normalisation procedure.
We found that the two different normalisation approaches actually
resulted in very similar miRNAs being detected as differentially
expressed.
Fifteen different miRNAs were identified as being significantly
up-regulated in response to the S. uberis challenge. No miRNAs
were identified as differentially expressed at 1 hpi. At 2 hpi, 2
miRNAs, bta-mir-29e and bta-mir-708, were found to be up-
regulated (Figure 4). bta-mir-29e was subsequently observed to be
down-regulated at 6hpi. At 4 hpi, bta-let-7b and bta-miR-98 were
up-regulated (Figure 5). Additionally, bta-miR-let-7c and bta-miR-
708 were observed to be up-regulated at 4 hpi when the
miRNAseq count data were normalised (both methods), but this
was not observed in the un-normalised data. At 6 hpi, 12 miRNAs
were found to be up-regulated (Figure 6), including bta-let-7b,
which was also up-regulated at 4 hpi.
Seven different miRNAs were identified as down-regulated in
response to the S. uberis challenge. No miRNAs were down-
regulated at 1 or 2 hpi. At 4 hpi, bta-miR-29b-2, bta-miR-193a,
and bta-miR-130a were down-regulated. At 6 hpi, bta-miR-29b-2,
bta-miR-29c, bta-miR-29e, bta-miR-100, bta-miR-130a and
Ensembl predicted miRNA ENSBTAG00000047296, were
down-regulated. Two miRNAs, bta-miR-29b-2 and bta-miR-
130a were down-regulated at both 4 and 6 hpi. Additionally, bta-
miR-15a, bta-miR-17, bta-miR-26a-2, bta-miR-29a, bta-miR-
29b-1, and bta-miR-193a were identified as down-regulated in the
normalised data (both methods), but not in the un-normalised
data. Fold changes in expression for miRNAs that are differentially
expressed at 4 and 6 hpi are shown in Figure S2 and S3.
These results indicate that there are rapid temporal changes in
the expression of miRNAs in response to a Gram-positive
infection, with different miRNA repertoires being identified as
differentially expressed at time-points that are 2 hours apart.
The miRNA Response to the Gram-positive S. uberis is
Markedly Different to the LPS miRNA Response
To date, many immune-relevant miRNAs have been identified
as part of the host response to lipopolysaccharide (LPS) stimulation
[47,48], which is frequently used to mimic a Gram-negative
bacterial infection. We have completed a literature survey and
identified over 145 miRNAs that have been shown to be
differentially expressed in response to LPS across multiple different
species and tissues (Table S4). Eighty-four of the 145 LPS
inducible miRNAs were found not be expressed above 1 tpm in
BMEs. Of the 21 miRNAs that we identified as being differentially
expressed in response to the Gram-positive S. uberis, only 9 of these
(bta-let-7d, bta-let-7b, bta-mir-98, bta-miR-100, bta-mir-130a,
bta-miR-193a, bta-miR-210, bta-miR-494, bta-miR-652) have
also been reported to be differentially expressed in response to LPS
in other species. Furthermore, 5 of these 9 (bta-miR-98, bta-miR-
100, bta-miR-193a, bta-miR-210, bta-miR-494) show an inverse
response to S. uberis infection in comparison to LPS. Most notably,
bta-miR-100 and bta-miR-494, which were previously identified
as up- and down-regulated, respectively, in mouse lung 6h post-
stimulation with LPS, showed the inverse response at the same
time-point in response to S. uberis infection [49,50]. This would
suggest that the miRNA response to Gram-positive bacteria may
be markedly different to Gram-negative.
Predicted Targets of Down-regulated miRNAs are
Enriched for Genes with a Role in Innate Immunity
Target genes that are potentially regulated by differentially
expressed miRNAs in response to S. uberis infection at 2, 4 and
6 hpi were predicted using two computational approaches,
miRanda [33,51] and TargetScan [34,35,36]. Given the high
false positive rates for miRNA target prediction, we identified only
those potential target genes that were predicted by both methods
(Table 2). Target genes that were not corroborated by one of the
two methods were discarded. In total 1,417 unique genes were
predicted to be targeted by differentially expressed miRNAs
(Table S5). This resulted in 2,491 miRNA-target interactions; 477
of these were targeted by down-regulated miRNAs; 1,921 were
targeted by up-regulated miRNAs; and 93 were targeted by both
Figure 5. Heatmap of miRNA expression (tpm) across infected
and control replicates for each 4 hpi differentially expressed
miRNA. The more red the color the more highly expressed that miRNA
is. The heatmap was generated using the R v2.14.1 heatmap package.
doi:10.1371/journal.pone.0057543.g005
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up and down-regulated miRNAs. Because of the difficulties in
accurately predicting miRNA targets, it is more appropriate to
examine whether broad functional categories of genes are
statistically over-represented among predicted target genes, rather
than focusing on individual gene predictions. Statistical analysis
(Hypergeometric test) revealed that the predicted target genes of
down-regulated miRNAs at 4 and 6 hpi were significantly
enriched (P= 0.01) in genes annotated by www.innatedb.com
[38] as having a role in innate immunity (Figure 7). The predicted
target genes of up-regulated miRNAs were not enriched for a role
in innate immunity suggesting that up and down-regulated
miRNAs target different processes in response to S. uberis infection.
Pathway analysis of the predicted gene targets of up-regulated
miRNAs (at 4 and 6 hpi), revealed that pathways which have been
previously implicated in mastitis are statistically enriched among
the predicted gene targets of up-regulated miRNAs (Table 3).
These pathways include MAPK signalling; Cytokine-Cytokine
Receptor Signalling and the JAK-STAT Signalling Pathway. The
MAPK signalling pathway, for instance, has been identified as one
of the top canonical pathways highlighted in a microarray study
examining the bovine mammary tissue response to mastitis, 20 hpi
with S. uberis [52]. Many of the other pathways that we identified
as statistically enriched among the predicted gene targets of up-
regulated miRNAs were also highlighted as significant in this
previous microarray study.
Taken together, these analyses strongly suggest that miRNAs
that are differentially expressed during infection of BMEs with S.
uberis are key regulators of the host response to this pathogen.
MicroRNA isomiRs
MicroRNA isomiRs are heterogeneous variants of canonical
miRNA species, which are, increasingly, being suggested to be of
functional importance [53]. It has been suggested that these
miRNA variants can be cell type specific, have functional
differences, and vary in their response to biological stimuli [54].
Figure 6. Heatmap of miRNA expression (tpm) across infected and control replicates for each 6 hpi differentially expressed miRNA.
The more red the color the more highly expressed that miRNA is. The heatmap was generated using the R v2.14.1 heatmap package.
doi:10.1371/journal.pone.0057543.g006
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Evidence suggests that although isomiRs show similar expression
patterns to their equivalent canonical miRNA, their targets can
vary [55]. Deletions at both the 59 and 39 end of isomiRs may
change the specificity of the seed binding region effecting miRNA
function.
We have found that the expression of isomiRs was common for
the majority of BME expressed miRNAs (Table 4). 100 known
miRNAs were found to have at least one isomiR expressed at
a level of .100 reads and more than 1,000 different isomiRs were
identified. Notably, in 40% of cases at least one isomiR was more
highly expressed than the miRbase consensus sequence, suggesting
that the isomiR should in fact be annotated as the consensus. On
further examination, we found that isomiR ‘nibbling’ was 1.4
more times likely than post-transcriptional additions and isomiR
editing was 2.3 times more likely to be 39 modified than 59
modified, agreeing with current literature [54]. That said, almost
40% of isomiRs were 59 modified, potentially impacting on which
targets they regulate, though the majority of 59 modified isomiRs
were expressed at low levels. Further work is required to determine
whether isomiRs have a functional role in response to infection.
Novel miRNA Discovery
In addition to profiling the expression of known miRNAs,
miRNAseq data can also be used to identify the expression of
potentially novel miRNAs. To do this, miRNAseq data from this
study was analysed using the software package, miRDeep2 [32].
We identified 21 high-confidence, putatively novel, bovine
miRNAs that were independently predicted in multiple BME
miRNAseq datasets (Table 5). Homology searching of the
miRBase database (v 19) [3] using BLAST [56] identified that 2
of the novel miRNAs had 100% identity to known miRNAs in
other species, ssc-miR-664-3p (pig) and hsa-miR-219-1 (human).
Additionally 5 of the novel bovine miRNAs had significant
homology with the bta-mir-2285 family. The bta-mir-2285 family
Figure 7. A network of miRNAs (arrow shapes) that were identified as being differentially expressed in BMEs at 4 hours post-
infection with S. uberis and their predicted target genes (circles). Red arrow shapes represent up-regulated miRNAs at 4 hpi; green down-
regulated. Red circles represent target genes that are annotated by www.innatedb.com as having a role in innate immunity. The network was
constructed and visualised in Cytoscape v2.8.2. [69].
doi:10.1371/journal.pone.0057543.g007
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has over 40 members spanning the entire bovine genome, [20].
Two additional novel miRNAs showed homology to the bta-mir-
2284 family. The remaining miRNAs did not show significant
homology to other known miRNAs in other species. However,
given the very high read counts observed for several of these
predicted miRNAs, and the fact that were independently predicted
in multiple different samples, it would suggest that many of these
predictions represent true novel bovine miRNAs.
Discussion
In this study, we have used a next generation sequencing
approach to profile the expression of bovine miRNAs at multiple
time-points in primary bovine mammary epithelial cells (BMEs)
infected in vitro with S. uberis, a causative agent of bovine mastitis.
In comparison to previous NGS studies investigating the host
miRNA response to infection, we have sequenced un-pooled
miRNA libraries to a previously unprecedented sequencing depth
from multiple replicates and controls across multiple time-points,
allowing us to explore statistically significant temporal changes in
miRNA expression in response to infection. Analysing over 450
million sequencing reads, we found that approximately 20% of
known bovine miRNAs are expressed in BMEs. A similar diversity
of miRNA expression has also been recently reported in other
tissues, including bovine retinal microvascular endothelial cells
(RMECs) [20] and in testicular and ovarian tissues [18]. As has
also been reported in other studies, there is a significant dynamic
range in the expression of known miRNAs in BMEs. A few
miRNAs are expressed at very high levels, with the majority being
expressed at low levels. The top 10 most highly expressed miRNAs
account for .80% of all aligned reads and are highly conserved
across species. Whether or not the other more lowly expressed
miRNAs play a significant biological role remains an open
question.
We have also found that the expression of isomiRs was common
for many of the BME expressed miRNAs. Most significantly, in
40% of cases, at least one isomiR was more highly expressed than
the miRbase consensus sequence, indicating that studies such as
ours can also be used to improve miRNA annotation. In
Table 2. miRNA target predictions by miRanda and TargetScan and their intersect.
Name
MiRanda Targets
(default) TargetScan = (PCT.0.9) TargetScan= (Quantile.0.9)
Number of
Intersecting
Targets
bta-let-7b 6377 576 58 311
bta-let-7d 5637 576 53 290
bta-let-7e 5447 576 60 280
bta-mir-98 5095 576 58 274
bta-mir-185 5696 0 338 177
bta-mir-494 2952 0 336 151
bta-mir-200c 3362 74 201 123
bta-mir-29c 5131 179 76 115
bta-mir-29b-2 5394 179 76 114
ENSBTAG00000047296 5523 0 204 108
bta-mir-29e 5488 0 174 93
bta-mir-708 6414 0 179 84
bta-mir-210 4012 0 206 83
bta-mir-193a 3337 0 160 76
bta-mir-130a 2630 87 76 63
bta-mir-24-2 2157 0 107 45
bta-mir-2342 4296 0 64 37
bta-mir-128-2 4266 83 0 33
bta-mir-128-1 4266 83 0 33
bta-mir-100 946 0 13 1
bta-mir-652 0 0 0 0
doi:10.1371/journal.pone.0057543.t002
Table 3. Pathway analysis of the predicted target genes of
up-regulated miRNAs 4 and 6 hours post-infection.
KEGG Pathway FDR 4 hpi FDR 6 hpi
MAPK signalling pathway 4.15E-33 2.79E221
Cytokine-cytokine receptor interaction 4.71E-08 1.96E232
Axon guidance ns 3.35E211
Calcium signalling pathway ns 1.15E206
MTOR signalling pathway ns 1.36E206
Colorectal cancer ns 1.81E206
Insulin signalling pathway ns 3.69E206
Jak-STAT signalling pathway ns 3.56E205
Fatty acid biosynthesis ns 4.86E205
*FDR= false discovery rate.
*hpi = hours post-infection.
doi:10.1371/journal.pone.0057543.t003
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particular, changes to the 59 of the consensus sequence could lead
to dramatically different target genes being computationally
predicted. We identified a large number of 59 isomiRs although
they were mostly expressed at low levels.
In addition to profiling known miRNAs, we have also analysed
the sequencing data to identify potentially novel bovine miRNAs.
Twenty-one high-confidence, putatively novel, bovine miRNAs
were identified independently across multiple different samples.
The mature sequences of two of the novel miRNAs were 100%
identical to known miRNAs in other species. Seven of the other
predicted miRNAs exhibited significant homology to two bovine
miRNA families, bta-mir-2284 and bta-mir-2285.
Few studies have previously investigated temporal changes in
global miRNA expression using an NGS approach [57], although
several have used microarray technology [58,59,60,61]. Thus far,
many immune-relevant miRNAs have been identified as part of
the host response to LPS stimulation [47,48]. We completed
a literature survey and identified more than 145 miRNAs across
multiple different species and tissues that have been shown to be
LPS responsive. In our study, the miRNA response to the Gram-
positive S. uberis was markedly different to the reported LPS
miRNA response. Over the 6 hour time-course, we identified 21
known bovine miRNAs as significantly differentially expressed in
response to the S. uberis challenge. Only 9 of these miRNAs have
also been reported to be differentially expressed in response to
LPS. For those in common, an inverse pattern of expression was
observed in 5 of the 9 cases suggesting that the miRNA response to
Gram-positive bacteria may be markedly different to Gram-
negative. Further global studies of the miRNA response to Gram-
positive and Gram-negative bacteria in the same tissue at the same
time-points will be required to confirm this.
It is notable that we found most miRNAs were differentially
expressed at different time-points post-infection, suggesting that
miRNAs exhibit rapid dynamics in their temporal expression. It is
also notable that the majority of miRNAs that we report as being
differentially expressed exhibit relatively subtle changes in gene
expression in response to infection. This subtle change in
expression is in line with existing literature and strengthens the
hypothesis that miRNAs are fine-tuners of gene expression
[48,62]. For example, miR-let-7d, miR-652 and miR-494
demonstrated similar levels of differential expression 6 hours post
LTA stimulation in mouse tissues [50].
Computational analysis revealed that the predicted target genes
of S. uberis down-regulated miRNAs were statistically enriched for
roles in innate immunity. This would suggest that these miRNAs
may significantly regulate the sentinel capacity of mammary
epithelial cells to mobilise the innate immune system [63].
Pathway analysis of the predicted targets of up-regulated miRNAs
has also identified the statistical over-representation of several
pathways previously implicated in the host response to mastitis,
such as the MAPK, JAK-STAT and other cytokine signaling
pathways. Furthermore, several of the differentially expressed
miRNAs have been shown to have roles in the immune systems of
other species. For example, bta-let-7 miRNAs were up-regulated
Table 5. Putative novel bovine miRNAs discovered through miRDeep2 analysis of miRNAseq data from 24 bovine primary
mammary epithelial cell samples.
Name *
Mature Sequence Best
miRBase BLAST Hit
(e-value ,1)
# Samples miRNA
is Predicted in Mature Tag Count ** Predicted Mature Sequence
bta-mir-6537 N/A 7 272,924 gugggacgcgugcguuuu
bta-mir-6538 N/A 22 22,094 auagccaguuggggaagaaugc
bta-mir-6539 N/A 20 9,687 acgcaauucuucaaaaucuuagc
bta-mir-6540 N/A 16 2,840 aaaaacuggcagcuucauguaa
bta-mir-2285i-1 bta-miR-2285i 13 2,241 aaaacuggaacgaacuuuugggc
bta-mir-2285f-3 bta-miR-2285f 18 2,202 aaaaccugaaugaacuucuugg
bta-mir-2284z-8 bta-miR-2284z 15 2,013 uaaaaguuugguuggguuuuu
bta-mir-664b ssc-miR-664-3p 20 1,736 uauucauuuaucucccagccuac
bta-mir-6541 N/A 8 1,501 uggagcggcugcacagagcgu
bta-mir-2285c-1 bta-miR-2285c 14 694 aaaaccugaagagacuuuuugg
bta-mir-6542 N/A 13 693 ugcuaccuagucugagugaguga
bta-mir-6544 N/A 18 332 uggugcucccuggagcugagc
bta-mir-6516 gga-miR-6516-5p 7 242 uuugcaguaacaggugugaac
bta-mir-219-1 hsa-miR-219-1-3p 3 173 agaguugagucuggacgucccg
bta-mir-6545 N/A 3 121 auggacugucaccugaggagc
bta-mir-2285m-6 bta-miR-2285m 2 107 aaaacccaaaugaacuuuuugg
bta-mir-2284b-1 bta-miR-2284b 5 86 aaauguucgcuuggcuuuuucc
bta-mir-2285f-4 bta-miR-2285f 2 64 agaaaguucauuuagguuuuuc
bta-mir-6546 N/A 4 52 cuuccucuuccgguuggcaga
bta-mir-6547 N/A 3 29 auucuccauuggauauaauagu
bta-mir-6643 gga-miR-6643-5p 2 21 cagggagggcaggggaggg
*Bovine miRNA names for the novel miRNAs have been assigned according to miRBase nomenclature rules.
**The number of reads aligning the mature miRNA.
doi:10.1371/journal.pone.0057543.t005
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at both 4 and 6 hours post-infection with S. uberis. The let-7 family
has been extensively described in the literature for having a role in
immunity. The down-regulation of let-7 family members, for
example, was shown to promote expression of IL-10 and IL-6 in
HeLa cells infected with Salmonella enterica serovar Typhimurium
[64]. The observed up-regulation of let-7 miRNAs in our study
may lead to the repression of anti-inflammatory cytokines to
promote innate immunity.
We also report the down-regulation of two other miRNAs, bta-
miR-29b-2 and bta-miR-130a, both of which have known roles in
immunity and infection in other species. miR-29a/miR-29b
down-regulation has been demonstrated to facilitate IFN-c up-
regulation in NK cells and TH1 cells [65,66]. IFN- c is well known
as an innate inflammatory mediator and its secretion promotes
host resistance against viral and intracellular bacteria. Further-
more, IFN-c mRNA expression has been demonstrated in human
mammary epithelial cells [67], suggesting that this may be
a relevant target in our model. LPS induced TNF-a expression
in neonatal and adult monocytes has been shown to be greatly
suppressed by the induction of miR-130a [68]. Taken together,
the evidence strongly suggests that the differentially expressed
miRNAs identified in this study are likely central regulators of the
innate immune response to S. uberis and thus represent potential
therapeutic targets or novel biomarkers of infection and in-
flammation.
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